3-hydroxykynurenine has been researched along with Bright Disease in 1 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haverkamp, GL | 1 |
| Loosman, WL | 1 |
| Franssen, CF | 1 |
| Kema, IP | 1 |
| van Diepen, M | 1 |
| Dekker, FW | 1 |
| Honig, A | 1 |
| Siegert, CE | 1 |
1 other study available for 3-hydroxykynurenine and Bright Disease
| Article | Year |
|---|---|
The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Depression; Female; Glomerulonephritis; Humans; Inciden | 2017 |